feed,title,long_url,short_url
FDA:PressReleases,FDA Authorizes Marketing of First Eyeglass Lenses to Slow Progression of Pediatric Myopia,http://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-first-eyeglass-lenses-slow-progression-pediatric-myopia,
FDA:PressReleases,FDA Removes Risk Evaluation and Mitigation Strategies (REMS) for Caprelsa (vandetanib),http://www.fda.gov/news-events/press-announcements/fda-removes-risk-evaluation-and-mitigation-strategies-rems-caprelsa-vandetanib,
